Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol

por Nakamura, Toshitaka, Takano, Toshiyuki, Fukunaga, Masao, Shiraki, Masataka, Matsumoto, Toshio
Publicado 2013

Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis

por Fujita, Takuo, Fukunaga, Masao, Itabashi, Akira, Tsutani, Kiichiro, Nakamura, Toshitaka
Publicado 2013

Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide

por Takeuchi, Yasuhiro, Kuroda, Tatsuhiko, Sugimoto, Toshitsugu, Shiraki, Masataka, Nakamura, Toshitaka
Publicado 2015

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis

por Hagino, Hiroshi, Takano, Toshiyuki, Fukunaga, Masao, Shiraki, Masataka, Nakamura, Toshitaka, Matsumoto, Toshio
Publicado 2012

Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER S...

por Hagino, Hiroshi, Yoshida, Seitaro, Hashimoto, Junko, Matsunaga, Masayuki, Tobinai, Masato, Nakamura, Toshitaka
Publicado 2014

Trends in Hip Fracture Incidence in Japan: Estimates Based on Nationwide Hip Fracture Surveys From 1992 to 2017

por Takusari, Eri, Sakata, Kiyomi, Hashimoto, Tsutomu, Fukushima, Yasumasa, Nakamura, Toshitaka, Orimo, Hajime
Publicado 2020

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis

por Nakamura, Toshitaka, Nakano, Tetsuo, Ito, Masako, Hagino, Hiroshi, Hashimoto, Junko, Tobinai, Masato, Mizunuma, Hideki
Publicado 2013

Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study

por Kuroda, Tatsuhiko, Shiraki, Masataka, Nakamura, Toshitaka, Suzuki, Hiroaki, Hiraishi, Kazuki, Sugimoto, Toshitsugu, Tanaka, Satoshi
Publicado 2021

Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?

por Sawabata, Noriyoshi, Nakamura, Toshitaka, Kawaguchi, Takeshi, Watanabe, Takashi, Ouji, Noriko Sageshima, Ito, Toshihiro, Taniguchi, Shigeki
Publicado 2020

Three years of treatment with minodronate in patients with postmenopausal osteoporosis

por Hagino, Hiroshi, Shiraki, Masataka, Fukunaga, Masao, Nakano, Tetsuo, Takaoka, Kunio, Ohashi, Yasuo, Nakamura, Toshitaka, Matsumoto, Toshio
Publicado 2011

Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study

por Shiraki, Masataka, Kuroda, Tatsuhiko, Takeuchi, Yasuhiro, Sugimoto, Toshitsugu, Tanaka, Satoshi, Suzuki, Hiroaki, Hiraishi, Kazuki, Nakamura, Toshitaka
Publicado 2021

Efficacy of the MRA-Based Road Mapping of the Para-Aortic Access Route before Mechanical Thrombectomy in Patients with Acute Ischemic Stroke

por Kobayashi, Satoshi, Osanai, Toshiya, Fujima, Noriyuki, Hamaguchi, Akiyoshi, Sugiyama, Taku, Nakamura, Toshitaka, Hida, Kazutoshi, Fujimura, Miki
Publicado 2022

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: fina...

por Mori, Satoshi, Hagino, Hiroshi, Sugimoto, Toshitsugu, Tanaka, Shiro, Mitomo, Yuji, Takahashi, Kaito, Sone, Teruki, Nakamura, Toshitaka, Soen, Satoshi
Publicado 2022

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide

por Tanaka, Sakae, Adachi, Taiji, Kuroda, Tatsuhiko, Nakamura, Toshitaka, Shiraki, Masataka, Sugimoto, Toshitsugu, Takeuchi, Yasuhiro, Saito, Mitsuru, Bilezikian, John P
Publicado 2014

Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

por Sone, Teruki, Kon, Naohiro, Gaither, Kenneth W., Okubo, Naoki, Osakabe, Taisuke, Nakayama, Yutaka, Fukunaga, Masao, Ito, Masako, Nakamura, Toshitaka
Publicado 2017

Comparison of Access Route for Endovascular Treatment by Time-Spatial Labeling Inversion Pulse (Time-SLIP) MRA and Contrast-Enhanced MRA

por Kobayashi, Satoshi, Osanai, Toshiya, Sugiyama, Taku, Fujima, Noriyuki, Takagi, Ryo, Yokota, Isao, Hamaguchi, Akiyoshi, Nakamura, Toshitaka, Hida, Kazutoshi, Fujimura, Miki
Publicado 2023

Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene

por Ohta, Hiroaki, Uemura, Yukari, Sone, Teruki, Tanaka, Shiro, Soen, Satoshi, Mori, Satoshi, Hagino, Hiroshi, Fukunaga, Masao, Nakamura, Toshitaka, Orimo, Hajime, Shiraki, Masataka
Publicado 2023

Association of Urinary Pentosidine Levels With the Risk of Fractures in Patients With Severe Osteoporosis: The Japanese Osteoporosis Intervention Trial‐05 (JOINT‐05)

por Tanaka, Shiro, Saito, Mitsuru, Hagino, Hiroshi, Mori, Satoshi, Nakamura, Toshitaka, Ohta, Hiroaki, Sone, Teruki, Takahashi, Kaito, Mitomo, Yuji, Sugimoto, Toshitsugu, Soen, Satoshi
Publicado 2022

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

por Sugimoto, Toshitsugu, Shiraki, Masataka, Fukunaga, Masao, Hagino, Hiroshi, Sone, Teruki, Nakano, Tetsuo, Kishimoto, Hideaki, Ito, Masako, Yoshikawa, Hideki, Kishida, Mitsukazu, Irie, Chika, Nakamura, Toshitaka
Publicado 2017

Phase separation of FSP1 promotes ferroptosis

por Nakamura, Toshitaka, Hipp, Clara, Santos Dias Mourão, André, Borggräfe, Jan, Aldrovandi, Maceler, Henkelmann, Bernhard, Wanninger, Jonas, Mishima, Eikan, Lytton, Elena, Emler, David, Proneth, Bettina, Sattler, Michael, Conrad, Marcus
Publicado 2023